CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-17 | Gabay Avraham CFO, Treasurer and Secretary | Grant or award · Stock Option (right to buy) | +33,146 | 33,146 | ||
| 2019-04-15 | Slager David Mark Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2019-04-10 | RAKIN KEVIN Director | Returned to the company · Stock Option (right to buy) | −10,000 | 0 | ||
| 2019-04-10 | RAKIN KEVIN Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-02-26 | KIDRON NADAV President and CEO | Returned to the company · Stock Option (right to buy) | −196,500 | 0 | ||
| 2019-02-26 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −104,000 | 0 | ||
| 2019-02-26 | Hasleton Mark Daniel VP Business Development | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2019-02-26 | Kidron Miriam Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +104,000 | 104,000 | ||
| 2019-02-26 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +196,500 | 196,500 | ||
| 2019-02-26 | Eisenberg Hilla CFO, Treasurer and Secretary | Grant or award · Stock Option (right to buy) | +37,000 | 37,000 | ||
| 2018-08-09 | Friedman Aviad Director | Purchase | +500 | $4.82 | $2K | 10,191 |
| 2018-08-09 | Friedman Aviad Director | Purchase | +2,000 | $4.98 | $10K | 12,191 |
| 2018-07-11 | KIDRON NADAV President and CEO | Purchase | +122 | $5.92 | $722 | 958,209 |
| 2018-07-10 | KIDRON NADAV President and CEO | Sale | −61 | $5.98 | $365 | 958,087 |
| 2018-05-03 | Hexter Joshua Chief Operating Officer | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2018-04-08 | Hexter Joshua Chief Operating Officer | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2018-01-31 | Eisenberg Hilla CFO, Treasurer and Secretary | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-01-31 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +97,000 | 97,000 | ||
| 2018-01-31 | Kidron Miriam Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2017-10-31 | Slager David Mark Director | Option exercise | +16,892 | $3.77 | $64K | 1,316,328 |
Page 14 of 18 · 349 trades